OTCPK:IHHH.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

IHH Healthcare Berhad, an investment holding company, provides healthcare services.


Snowflake Analysis

Adequate balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IHHH.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

IHHH.F

3.1%

US Healthcare

2.5%

US Market


1 Year Return

n/a

IHHH.F

17.3%

US Healthcare

16.3%

US Market

Return vs Industry: Insufficient data to determine how IHHH.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how IHHH.F performed against the US Market.


Shareholder returns

IHHH.FIndustryMarket
7 Day0%3.1%2.5%
30 Day0%6.9%5.6%
90 Dayn/a8.1%16.4%
1 Yearn/a18.9%17.3%18.8%16.3%
3 Year6.3%6.3%36.5%30.5%45.1%35.7%
5 Year-14.6%-14.6%48.7%38.3%75.8%56.8%

Price Volatility Vs. Market

How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?

906.84x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: IHHH.F ($1.35) is trading above our estimate of fair value ($1.21)

Significantly Below Fair Value: IHHH.F is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IHHH.F is poor value based on its PE Ratio (906.8x) compared to the US Healthcare industry average (27.9x).

PE vs Market: IHHH.F is poor value based on its PE Ratio (906.8x) compared to the US market (18.8x).


Price to Earnings Growth Ratio

PEG Ratio: IHHH.F is poor value based on its PEG Ratio (21.8x)


Price to Book Ratio

PB vs Industry: IHHH.F is good value based on its PB Ratio (2x) compared to the US Healthcare industry average (3.1x).


Next Steps

Future Growth

How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

41.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IHHH.F's forecast earnings growth (41.6% per year) is above the savings rate (2.2%).

Earnings vs Market: IHHH.F's earnings (41.6% per year) are forecast to grow faster than the US market (22.9% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IHHH.F's revenue (10.8% per year) is forecast to grow faster than the US market (9.4% per year).

High Growth Revenue: IHHH.F's revenue (10.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IHHH.F's Return on Equity is forecast to be low in 3 years time (4.9%).


Next Steps

  • Explore growth companies in the Healthcare industry.

Past Performance

How has IHH Healthcare Berhad performed over the past 5 years?

-15.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IHHH.F has a large one-off loss of MYR683.2M impacting its March 31 2020 financial results.

Growing Profit Margin: IHHH.F's current net profit margins (0.4%) are lower than last year (4.7%).


Past Earnings Growth Analysis

Earnings Trend: IHHH.F's earnings have declined by 15.9% per year over the past 5 years.

Accelerating Growth: IHHH.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IHHH.F had negative earnings growth (-90.7%) over the past year, making it difficult to compare to the Healthcare industry average (19.3%).


Return on Equity

High ROE: IHHH.F's Return on Equity (0.6%) is considered low.


Next Steps

Financial Health

How is IHH Healthcare Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: IHHH.F's short term assets (MYR8.3B) exceed its short term liabilities (MYR6.2B).

Long Term Liabilities: IHHH.F's short term assets (MYR8.3B) do not cover its long term liabilities (MYR12.1B).


Debt to Equity History and Analysis

Debt Level: IHHH.F's debt to equity ratio (37.4%) is considered satisfactory.

Reducing Debt: IHHH.F's debt to equity ratio has increased from 20.5% to 37.4% over the past 5 years.

Debt Coverage: IHHH.F's debt is well covered by operating cash flow (24.5%).

Interest Coverage: IHHH.F's interest payments on its debt are well covered by EBIT (4.4x coverage).


Balance Sheet


Next Steps

Dividend

What is IHH Healthcare Berhad current dividend yield, its reliability and sustainability?

0.73%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: IHHH.F's dividend (0.73%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.65%).

High Dividend: IHHH.F's dividend (0.73%) is low compared to the top 25% of dividend payers in the US market (4.45%).


Stability and Growth of Payments

Stable Dividend: IHHH.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: IHHH.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: IHHH.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IHHH.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.6yrs

Average management tenure


CEO

Kelvin Loh (46 yo)

0.58

Tenure

RM9,936,000

Compensation

Dr. Chi-Keon Loh, also known as Kelvin, serves as Managing Director and Chief Executive Officer of IHH Healthcare Berhad since January 1, 2020 and serves as its Executive Director since July 01, 2019. He h ...


CEO Compensation Analysis

Compensation vs Market: Kelvin's total compensation ($USD2.37M) is below average for companies of similar size in the US market ($USD11.30M).

Compensation vs Earnings: Insufficient data to compare Kelvin's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Chi-Keon Loh
MD, CEO & Executive Director0.58yrRM9.94mno data
Soon Teck Low
Group Chief Financial Officer4.58yrsno datano data
Heng Joo Sim
Group Chief Operating Officer0.58yrno datano data
Penelope Koh
Vice President of Investor Relationsno datano datano data
Ida Binti Ab Rahim
Group General Counsel & Company Secretaryno datano datano data
Angela Ryan
Group Chief Human Resources Officer0.92yrno datano data
Nili Shayrina Saat
Group Head of Risk Management1.75yrsno datano data
Boon Kheng Chan
Group Head of Strategic Planning & Business Development (M&A) and CEO of South East Asia Ops. Div.2.58yrsno datano data
Ching Seow
Company Secretaryno datano datano data
Abdul Baba
President of IMU Health Sdn Bhd and C.E.O. & Vice-Chancellor of IMU Education Sdn Bhd4.58yrsno datano data
Tahsin Guney
Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S031.42yrsno datano data

1.6yrs

Average Tenure

48yo

Average Age

Experienced Management: IHHH.F's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Chi-Keon Loh
MD, CEO & Executive Director0.58yrRM9.94mno data
Shirish Apte
Independent Non-Executive Director5.92yrsRM975.00kno data
Mohammed Bin Hashim
Independent Non Executive Chairman2.58yrsRM978.00kno data
Mehmet Aydinlar
Non-Independent & Non-Executive Director8.58yrsRM9.29m5.92%
MYR 683.1m
Farid Bin Mohamed Sani
Non-Independent & Non-Executive Director0.75yrRM51.00kno data
Jill Watts
Independent Non Executive Director2.33yrsRM485.00kno data
Rossana Binti Ahmad Rashid
Independent Non-Executive Director8.33yrsRM1.14mno data
Takeshi Saito
Non-Independent & Non-Executive Director1.42yrsRM414.00kno data
Masato Sugahara
Non Independent Non Executive Director0.33yrno datano data
Tomo Nagahiro
Non Independent Non Executive Alternate Director0.33yrno datano data
Eugene Wong
Non Independent Non Executive Alternate Director1.08yrsno datano data
Shilin Ong
Non Independent Non Executive Alternate Director1yrno datano data

1.3yrs

Average Tenure

51yo

Average Age

Experienced Board: IHHH.F's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IHH Healthcare Berhad
  • Ticker: IHHH.F
  • Exchange: OTCPK
  • Founded: 2010
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: RM48.275b
  • Listing Market Cap: RM11.538b
  • Shares outstanding: 8.78b
  • Website: https://www.ihhhealthcare.com

Number of Employees


Location

  • IHH Healthcare Berhad
  • Pantai Hospital Kuala Lumpur
  • Level 11, Block A
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 59100
  • Malaysia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IHHKLSE (Bursa Malaysia)YesOrdinary SharesMYMYRJul 2012
Q0FSGX (Singapore Exchange)YesOrdinary SharesSGSGDJul 2012
IHHH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJul 2012

Biography

IHH Healthcare Berhad, an investment holding company, provides healthcare services. It provides primary care services, such as treatment of basic illnesses, routine check-ups, and vaccinations. The company ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/08 01:05
End of Day Share Price2020/06/15 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.